Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Pammi, Mohan ^a   Abrams, Steven A ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CHILDREN S NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN; PROBIOTIC AGENT;

ADVERSE OUTCOME; AGE; ALL CAUSE MORTALITY; ARTIFICIAL MILK; BIRTH WEIGHT; BREAST MILK; CHRONIC LUNG DISEASE; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; DRUG SAFETY; ENCEPHALOMALACIA; EVIDENCE BASED MEDICINE; FUNGEMIA; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; INFANT; LENGTH OF STAY; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEUROLOGICAL COMPLICATION; NEWBORN; NEWBORN SEPSIS; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVOR; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ENTEROCOLITIS, NECROTIZING; INFANT, PREMATURE, DISEASES; LACTOBACILLUS RHAMNOSUS; ORAL DRUG ADMINISTRATION; SEPSIS;

ADMINISTRATION, ORAL; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LACTOBACILLUS RHAMNOSUS; LACTOFERRIN; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 84934326069     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007137.pub4     Document Type: Review

References (53)

1. Akin IM, Atasay B, Dogu F, Okulu E, Arsan S, Karatas HD, et al. Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells. American Journal of Perinatology 2014 May 16 [Epub ahead of print]. [PUBMED: 24839144]
2. Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H, et al. Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, The Italian Society of Neonatology. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009;302(13):1421-8. [PUBMED: 19809023]
3. Manzoni P, Stolfi I, Messner H, Cattani S, Laforgia N, Romeo MG, et al. Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, The Italian Society of Neonatology. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 2012;129(1):116-23. [PUBMED: 22184648]
4. Manzoni P, Meyer M, Stolfi I, Rinaldi M, Cattani S, Pugni L, et al. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Human Development 2014;90 Suppl 1:S60-5. [PUBMED: 24709463]
5. Ochoa . Pilot Study: Lactoferrin for Prevention of Neonatal Sepsis (NEOLACTO). www.clinicaltrials.gov 2011. [: NCT01264536]
6. Sherman MP, Niklas V, Radmacher P, Sherman J, Wertheimer F, Adamkin DH. A clinical trial of talactoferrin to reduce infection in very preterm infants: safety and efficacy. Pediatric Academic Societies Annual Conference. 2013. [: 3360.7]
7. King JC Jr, Cummings GE, Guo N, Trivedi L, Readmond BX, Keane V, et al. A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infants. Journal of Pediatric Gastroenterology and Nutrition 2007;44(2):245-51. [PUBMED: 17255839]
8. Ochoa T, Chea-Woo E, Baiocchi N, Pecho I, Campos M, Prada A, et al. Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children. Journal of Pediatrics 2013;162(2):349-56. [PUBMED: 22939927]
9. Barrington K. Randomized controlled pilot trial of lactoferrin for prevention of infections in very preterm newborns. www.controlled-trials.com/ISRCTN66482337 (accessed 10 July 2014).
10. Buonocore G. Supplementation with lactoferrin in preterm newborns (lactoprenew). clinicaltrials.gov/show/NCT01172236 (accessed 10 July 2014).
11. Effect of prebiotic or lactoferrin supplementation in formula on the gut flora of preterm infants. www.controlled-trials.com/ISCRTN71737811 (accessed 10 July 2014).
12. El-Mokadem M. Oral lactoferrin supplementation for prevention of sepsis in preterm neonate. clinicaltrials.gov/show/NCT01821989 (accessed 10 July 2014).
13. McGuire W. Enteral lactoferrin In neonates. www.controlled-trials.com/ISRCTN88261002 (accessed 10 July 2014).
14. Ochoa T. Lactoferrin for prevention of sepsis in infants (NEOLACTO). clinicaltrials.gov/show/NCT01525316 (accessed 10 July 2014).
15. Tarnow-Mordi W. Lactoferrin infant feeding trial (LIFT) to prevent sepsis and death in preterm infants. www.anzctr.org.au/ACTRN12611000247976 (accessed 10 July 2014).
16. Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Current Opinion in Infectious Diseases 2006;19(3):290-7. [PUBMED: 16645492]
17. Artym J, Zimecki M, Kruzel ML. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin. International Immunopharmacology 2004;4(9):1149-57. [PUBMED: 15251111]
18. Barboza M, Pinzon J, Wickramasinghe S, Froehlich J, Moeller I, Smilowitz J, et al. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Molecular Cell Proteomics 2012;11(6):M111.015248. [PUBMED: 22261723]
19. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotising enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187(1):1-7. [PUBMED: 413500]
20. Bellamy W, Takase M, Wakabayashi H, Kawase K, Tomita M. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. Journal of Applied Bacteriology 1992;73(6):472-9. [PUBMED: 1490908]
21. Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. American Journal of Respiratory Cell and Molecular Biology 1997;17(1):3-9. [PUBMED: 9224203]
22. Buccigrossi V, de Marco G, Bruzzese E, Ombrato L, Bracale I, Polito G, et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatric Research 2007;61(4):410-4. [PUBMED: 17515863]
23. Edde L, Hipolito RB, Hwang FF, Headon DR, Shalwitz RA, Sherman MP. Lactoferrin protects neonatal rats from gut-related systemic infection. American Journal of Physiology. Gastrointestinal and Liver Physiology 2001;281(5):G1140-50. [PUBMED: 11668022]
24. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cellular and Molecular Life Sciences 2005;62(22):2588-98. [PUBMED: 16261252]
25. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6. [PUBMED: 18436948]
26. Hayes TG, Falchook GF, Varadhachary GR, Smith DP, Davis LD, Dhingra HM, et al. Phase I trial of oral talactoferrin alfa in refractory solid tumors. Investigational New Drugs 2006;24(3):233-40. [PUBMED: 16193240]
27. Iwasa M, Kaito M, Ikoma J, Takeo M, Imoto I, Yamauchi K, et al. Lactoferrin inhibits hepatitis C virus viremia in chronic hepatitis C patients with high viral loads and HCV genotype 1b. American Journal of Gastroenterology 2002;97(3):766-7. [PUBMED: 11922584]
28. Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK, Swart PJ. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrobial Agents and Chemotherapy 1999;43(11):2635-41. [PUBMED: 10543740]
29. Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. International Journal of Epidemiology 2006;35(3):706-18. [PUBMED: 16556647]
30. Leitch EC, Willcox MD. Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Current Eye Research 1999;19(1):12-9. [PUBMED: 10415452]
31. Levy SB. Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilize our environment. BMJ 1998;317(7159):612-3. [PUBMED: 9727983]
32. Lin PW, Stoll BJ. Necrotizing enterocolitis. Lancet 2006;368(9543):1271-83. [PUBMED: 17027734]
33. Lingappan K, Arunachalam A, Pammi M. Lactoferrin and the newborn: current perspectives. Expert Reviews of Anti-Infective Therapy 2013;11(7):695-707. [PUBMED: 23879609]
34. Neish AS. Molecular aspects of intestinal epithelial cell-bacterial interactions that determine the development of intestinal inflammation. Inflammatory Bowel Diseases 2004;10(2):159-68. [PUBMED: 15168817]
35. Nibbering PH, Ravensbergen E, Welling MM, van Berkel LA, van Berkel PH, Pauwels EK, et al. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infection and Immunity 2001;69(3):1469-76. [PUBMED: 11179314]
36. Turin CG, Zea-Vera A, Pezo A, Cruz K, Zegarra J, Bellomo S, et al. NEOLACTO Research Group. Lactoferrin for prevention of neonatal sepsis. Biometals 2014;27(5):1007-16. [PUBMED: 24935001]
37. Pierce A, Colavizza D, Benaissa M, Maes P, Tartar A, Montreuil J, et al. Molecular cloning and sequence analysis of bovine lactotransferrin. European Journal of Biochemistry 1991;196(1):177-84. [PUBMED: 2001696]
38. Speer CP. Inflammatory mechanisms in neonatal chronic lung disease. European Journal of Pediatrics 1999;158(Suppl 1):S18-22. [PUBMED: 10592094]
39. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91. [PUBMED: 12165580]
40. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292(19):2357-65. [PUBMED: 15547163]
41. Stoll BJ. Infections of the neonatal infant. In: Behrman RE, Kliegman R, Jenson HB editor(s). Nelson's Textbook of Pediatrics. 17th Edition. Philadelphia: Saunders, 2004:623-40.
42. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatric Infectious Disease Journal 2005;24(7):635-9. [PUBMED: 15999007]
43. Tanaka K, Ikeda M, Nozaki A, Kato N, Tsuda H, Saito S, et al. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Japanese Journal of Cancer Research 1999;90(4):367-71. [PUBMED: 10363572]
44. Togawa J, Nagase H, Tanaka K, Inamori M, Umezawa T, Nakajima A, et al. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. American Journal of Physiology. Gastrointestinal and Liver Physiology 2002;283(1):G187-95. [PUBMED: 12065306]
45. Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochemistry and Cell Biology 2002;80(1):109-12. [PUBMED: 11908633]
46. Trumpler U, Straub PW, Rosenmund A. Antibacterial prophylaxis with lactoferrin in neutropenic patients. European Journal of Clinical Microbiology and Infectious Diseases 1989;8(4):310-3. [PUBMED: 2497005]
47. Valenti P, Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cellular and Molecular Life Sciences 2005;62(22):2576-87. [PUBMED: 16261253]
48. Venkatesh M, Pham D, Kong L, Weisman L. Prophylaxis with lactoferrin, a novel antimicrobial agent, enhances survival in a neonatal rat model of co-infection. Advances in Therapy 2007;24(5):941-54. [PUBMED: 18029319]
49. Volpe JJ. Neurology of the Newborn. 3rd Edition. Philadelphia, London: WB Saunders, 1995.
50. Zagulski T, Lipinski P, Zagulska A, Broniek S, Jarzabek Z. Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. British Journal of Experimental Pathology 1989;70(6):697-704. [PUBMED: 2690922]
51. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet 2005;365(9465):1175-88. [PUBMED: 15794973]
52. Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews 2010, Issue 5. [DOI: 10.1002/14651858.CD007137.pub2]
53. Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD007137.pub3]